Structural heterogeneity of apolipoprotein B‐100
The FEBS Journal · 2026
DOI: 10.1111/febs.70451 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2026. Verfasst von Altaira D Dearborn und 2 weiteren Autor:innen. Beteiligte Einrichtung: Structural Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health,…. Hauptthemen laut MEDLINE: Apolipoprotein B-100, Lipoproteins, LDL, Receptors, LDL. Die Arbeit nennt 22 Literaturangaben. Gefördert von: NHLBI NIH HHS, National Institute of Allergy and Infectious Diseases, Leducq Foundation for Cardiovascular Research.
Abstract (Originalsprache)
Cardiovascular disease is a major cause of human morbidity and mortality. Drug strategies for the prevention of the disease are largely centered on the interaction of low‐density lipoprotein receptor (LDLR) with the apolipoprotein B‐100 (apoB‐100) protein on low‐density lipoprotein (LDL). Recently, the structure of apoB‐100 on LDL was determined in the absence and presence of LDLR, using cryo‐electron microscopy. A remarkable structural feature of apoB‐100 is the lack of any significant tertiary structure within the C‐terminal two‐thirds of the protein (>3000 residues). Instead, apoB‐100 forms amphipathic helices and β‐sheets on the phospholipid surface of LDL, which envelops its neutral lipid core. The apoB‐100 ligand binding domain for LDLR includes multiple points on a circumferential β‐belt and on the N terminus. In the course of this study, we also observed several instances of structural heterogeneity in apoB‐100. The various conformations may allow apoB‐100 to accommodate different size lipoprotein particles and to permit recognition by other apolipoproteins or receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Structural Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National, Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
ORCID-Profile: Joseph Marcotrigiano
Förderung
- NHLBI NIH HHS
- National Institute of Allergy and Infectious Diseases
- Leducq Foundation for Cardiovascular Research
- Division of Intramural Research
- National Heart, Lung, and Blood Institute
Zitieren
APA
Dearborn, A. D., Remaley, A. T., & Marcotrigiano, J. (2026). Structural heterogeneity of apolipoprotein B‐100. The FEBS Journal. https://doi.org/10.1111/febs.70451
Vancouver
Dearborn AD, Remaley AT, Marcotrigiano J. Structural heterogeneity of apolipoprotein B‐100. The FEBS Journal. 2026. doi:10.1111/febs.70451
BibTeX
@article{Dearborn2026,
author = {Dearborn, Altaira D and Remaley, Alan T and Marcotrigiano, Joseph},
title = {Structural heterogeneity of apolipoprotein B‐100},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70451}
}
EUVIMED